Loading…

Predicting macular hole closure with ocriplasmin based on spectral domain optical coherence tomography

Purpose To assess the preoperative features of patients with idiopathic macular hole (IMH) and vitreomacular adhesion (VMA) treated with ocriplasmin (OCP) that can predict successful closure. Method Data were prospectively collected on all patients with IMH treated with OCP in three British ophthalm...

Full description

Saved in:
Bibliographic Details
Published in:Eye (London) 2016-05, Vol.30 (5), p.740-745
Main Authors: Steel, D H W, Parkes, C, Papastavrou, V T, Avery, P J, El-Ghrably, I A, Habib, M S, Sandinha, M T, Smith, J, Stannard, K P, Vaideanu-Collins, D, Hillier, R J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To assess the preoperative features of patients with idiopathic macular hole (IMH) and vitreomacular adhesion (VMA) treated with ocriplasmin (OCP) that can predict successful closure. Method Data were prospectively collected on all patients with IMH treated with OCP in three British ophthalmic centres. Several preoperative variables were recorded including the IMH base diameter (BD), minimum linear diameter (MLD), and VMA width measured on spectral domain optical coherence tomography. Several other IMH indices were derived including a ‘width factor’, defined as the BD minus the MLD in μ m. The occurrence of VMA release and hole closure were used as the main outcome measures. Results Thirty-three patients in total with IMH were treated with OCP. Two patients developed rhegmatogenous retinal detachment and were excluded. The mean age of the remaining 31 patients was 71 years, and 71% were female. VMA release occurred in 19 of the 31 (61%) patients and macular hole closure in 11 (35%). Width factor was the most predictive feature for closure on multivariate analysis. The deviance R 2 was 67% ( P
ISSN:0950-222X
1476-5454
DOI:10.1038/eye.2016.42